Popular semaglutide-based drugs used for weight loss may reduce chronic and acute pain, which could make them a promising ...

More than 48 million Americans 12 years or older had a substance use disorder in 2022, yet only 24 percent received treatment ...

Metsera has brought in over $500m in funding in just seven months as it looks to enter the competitive weight loss arena.

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

Even when patients are aware of the risks, adherence to diet, exercise, and medication remains low—even among those who have ...

I was wondering whether Ozempic might be prescribed for somebody who gained weight due to antipsychotics or drugs for depression. I read some years ago that the ...

A manufacturer-funded study found a significant decrease in annual total medical costs in patients with overweight/obesity ...

As an alternative, some doctors have been prescribing metformin—an oral diabetes drug—off-label for weight loss. But how does ...

DehydraTECH clinical test article manufacturing has been completed KELOWNA, BC / ACCESSWIRE / November 13, 2024 / Lexaria Bioscience Corp. (Nasdaq:LEXX, LEXXW) (the "Company" or "Lexaria"), a global ...

Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results ...

Oral semaglutide: Less common type of semaglutide. Administered either as a tablet or liquid drops, typically in a daily ...

While Novo Nordisk says CagriSema will help users lose up to 25% of weight, duration will be clear when final results of its ...